TEOSYAL® RHA Ultra Deep and Perlane-L® for the Correction of Nasolabial Folds
A Controlled, Randomized, Double-Blinded, Within-Subject, Multicenter, Prospective Clinical Study of TEOSYAL® RHA (Resilient Hyaluronic Acid) Ultra Deep Versus Perlane-L® in the Treatment of Moderate to Severe Nasolabial Folds
Sponsor: Teoxane SA
This NA trial investigates Nasolabial Folds, Wrinkles and is currently completed. Teoxane SA leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Apr 2018 — Jun 2018 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Dec 2017 — Apr 2018 [monthly]
Completed NA
Status: Withheld → Completed
-
Feb 2017 — Dec 2017 [monthly]
Withheld NA
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Teoxane SA
- ethica Clinical Research Inc.
For direct contact, visit the study record on ClinicalTrials.gov .